Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
In a surgical biopsy, a medical professional removes samples of cells or tissue that pathologists analyze for diseases such as cancer. By delivering these capabilities through a compact, AI-powered imaging system within the treatment room, Invenio aims to support rapid clinical decision-making.
This technology will help surgeons make intraoperative decisions when performing a biopsy or surgery, said Chris Freudiger, chief technology officer of Silicon Valley-based Invenio. They'll be able to rapidly evaluate whether the tissue sample contains cancerous cells, decide whether they need to take another tissue sample and, with the AI models Invenio is developing, potentially make a molecular diagnosis for personalized medical treatment within minutes.
Quicker diagnosis enables quicker treatment. It's especially critical for aggressive types of cancer that could grow or spread significantly in the weeks it takes for biopsy results to return from a dedicated pathology lab.
Invenio is a member of NVIDIA Inception, a program that provides cutting-edge startups with technological support and AI platform guidance. The company accelerates AI training and inference using NVIDIA GPUs and software libraries.
Laser Focus on Cancer Care The NIO Laser Imaging System accelerates the imaging of fresh tissue biopsies. Invenio's NIO Laser Imaging System is a digital pathology tool that accelerates the imaging of fresh tissue biopsies. It's been used in thousands of procedures in the U.S. and Europe. In 2021, it received the CE Mark of regulatory approval in Europe.
The company plans to adopt the NVIDIA Jetson Orin series of edge AI modules for its next-generation imaging system, which will feature near real-time AI inference accelerated by the NVIDIA TensorRT SDK.
We're building a layer of AI models on top of our imaging capabilities to provide physicians with not just the diagnostic image but also an analysis of what they're seeing, Freudiger said. With the AI performance provided by NVIDIA Jetson at the edge, they'll be able to quickly determine what kinds of cancer cells are present in a biopsy image.
Invenio uses a cluster of NVIDIA RTX A6000 GPUs to train neural networks with tens of millions of parameters on pathologist-annotated images. The models were developed using the TensorFlow deep learning framework and trained on images acquired with NIO imaging systems.
The most powerful capability for us is the expanded VRAM on the RTX A6000 GPUs, which allows us to load large batches of images and capture the variability of features, Freudiger said. It makes a big difference for AI training.
On the Path to Clinical Deployment One of Invenio's AI products, NIO Glioma Reveal, is approved for clinical use in Europe and available for research use in the U.S. to help identify areas of cancerous cells in brain tissue.
A team of Invenio's collaborators from the University of Michigan, New York University, University of California San Francisco, the Medical University of Vienna and University Hospital of Cologne recently developed a deep learning model that can find biomarkers of cancerous tumors with 93% accuracy in 90 seconds.
With this ability to analyze different molecular subtypes of cancer within a tissue sample, doctors can predict how well a patient will respond to chemotherapy - or determine whether a tumor has been successfully removed during surgery.
Beyond its work on brain tissue analysis, Invenio this year announced a clinical research collaboration with Johnson & Johnson's Lung Cancer Initiative to develop and validate an AI solution that can help evaluate lung biopsies. The AI model will help doctors rapidly determine whether collected tissue samples contain cancer.
Lung cancer is the world's deadliest form of cancer, and in the U.S. alone, lung nodules are found in over 1.5 million patients each year. Once approved for clinical use, Invenio's NIO Lung Cancer Reveal tool aims to shorten the time needed to analyze tissue biopsies for these patients.
As part of this initiative, Invenio will run a clinical study before submitting the NVIDIA Jetson-powered AI solution for FDA approval.
Subscribe to NVIDIA healthcare news.
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/07/2026
The National Film and Video Foundation (NFVF) is pleased to announce that the ca...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Manfrotto Introduces UNCOVER, the new premium camera bag collection for modern h...
01/07/2026
Blackmagic Design Powers Houston Tamil Sangam Literacy Competition
Brie Clayton July 1, 2026
0 Comments
Volunteers use ATEM Mini Pro, Blackmagic Desig...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
PlayBox Technology has published State of Broadcast Infrastructure 2026, an in-depth industry research report examining the technologies, operational challenges...
01/07/2026
LONDON, UK, 1 JULY Jigsaw24 has appointed Alan Henry as Head of Sales for Media and Entertainment, reinforcing its continued investment in helping broadcaster...
01/07/2026
Content Vault, the patent-pending secure content distribution platform protecting high-value media from disclosures, theft and unauthorised access, today announ...
01/07/2026
Bitcentral, Inc. a leading provider of enterprise software and digital media solutions for news, sports and entertainment broadcasters, as well as streaming pla...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/07/2026
Groundbreaking First Nations Screen Business Accelerator launched through nation...
01/07/2026
Chyron Launches the All-New Chyron Academy: A Reimagined, Hands-On Learning Expe...
01/07/2026
Amplium Captures Kawasaki Brave Thunders Game with Blackmagic URSA Cine Immersiv...
01/07/2026
Boris FX Optics Expands Plugin Support to Apple Photos, Capture One, and Affinit...
01/07/2026
Apple today introduced power-packed updates to Apple Creator Studio, a groundbre...
01/07/2026
Nectar360, the Retail Media, Loyalty and Insights business of the Sainsburys Gro...
01/07/2026
9.2 million streams on RT Player between 11 and 28 June
Reach of 2.9 million viewers during Group stages of FIFA World Cup on RT 2
23 million video views acr...
30/06/2026
Could your journalism reach an international stage?
Entries are now open for the Thomson Foundation's Young Journalist Award 2026, one of the most prestigi...
30/06/2026
As Brazil's only way for fans to see all 104 matches, YouTube channel proves the power of digital...
30/06/2026
Brings together saturation & lo-fi effects
Following on from the release of their Voxcraft vocal-processing plug-in, UJAM have announced the launch of Retro...
30/06/2026
New IR reverb engine, Juno-inspired chorus & more
The latest version of Rapid Flow's hardware-emulation synth plug-in expands on its predecessor with a ...
30/06/2026
Excels at heavy-handed VCA compression
For their latest release, Shy Audio have recreated the crunchy' sound of a rackmount compressor that found its w...
30/06/2026
Component scarcity drives cost increases
Shortly after Apple's CEO Tim Cook acknowledged that cost increases would soon be inevitable , the company hav...
30/06/2026
Statement regarding GetUp Save Our SBS' campaign
30 June, 2026
Media releases
The GetUp Save Our SBS' campaign is an independent initiative. SBS ...
30/06/2026
Hitachi and Bank Pekao S.A. have completed the installation of the first Hitachi...
30/06/2026
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
MainStreaming, the award-winning and innovative Edge Video Delivery Network, today announced that it has been selected by ITV to support the delivery of ITVX, I...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
When Wheel of Fortune and Jeopardy! needed to upgrade their wireless communications system, they turned to Clear-Com FreeSpeak wireless for their iconic televi...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/06/2026
Other World Computing Launches New Atlas Core Line with 256GB CFExpress 4.0 Type...
Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
